在德国现实环境中使用MANAGE-PD工具:一项跨部门研究
Martin Südmeyer1,2, David J Pedrosa3, Frank Siebecker4
1Department of Neurology, Ernst-von-Bergmann Klinikum, 14467 Potsdam, Germany.
Brain sciences
|July 27, 2024
概括
MANAGE-PD帮助医生识别需要治疗调整的帕金森病患者. 帕金森检查患者工具显示与医生评估的高度一致,有助于更好的患者护理.
科学领域:
- 神经学 神经学
- 临床信息学 临床信息学
背景情况:
- 帕金森病 (PD) 管理需要工具来识别有不充分控制症状的患者.
- MANAGE-PD是一个基于网络的医生工具,在德国提供患者版本 (帕金森检查).
- 此前,关于MANAGE-PD临床功效的前性研究缺乏.
研究的目的:
- 在德国评估MANAGE-PD和帕金森检查的实际临床实用性.
- 为了评估医生判断,MANAGE-PD和帕金森病之间的一致性,检查评估PD症状控制.
主要方法:
- 一项非干预性研究,涉及德国19个地点的278名帕金森病患者 (2022年).
- 医生通过自己的判断和MANAGE-PD工具对疾病控制进行了评分.
- 患者完成了帕金森检查自我评估工具.
- 在医生评估,MANAGE-PD和帕金森检查结果之间进行了一致性分析.
主要成果:
- 在医生判断和MANAGE-PD疾病控制评估之间发现了57.6%的一致性.
- 与一般神经科医生实践 (43.7%) 相比,在专科诊所 (63.9%) 的一致性更高.
- 在帕金森检查中观察到医生和患者反应之间的高度一致 (>80%).
结论:
- 对于一般神经病学家来说,MANAGE-PD对于识别需要转诊到专家护理的PD患者非常有价值.
- 帕金森检查自我评估工具显示出有希望的结果,并保证了更广泛的采用.
- 这些工具可以改善对不充分控制的帕金森病症状的识别.
相关概念视频
Methods of Documentation II: POMR
The Problem-Oriented Medical Record (POMR) revolutionized medical record-keeping by introducing a systematic approach focusing on the patient's problems rather than merely listing symptoms. Dr. Lawrence Weed's introduction of this method in the 1960s marked a significant advancement in medical documentation. The POMR framework consists of four key components: the database, problem list, plan of care, and progress notes.
Methods of Documentation VI: Case Management Model
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...
For example, a patient with a chronic illness...
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.


